Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Azathioprine
Drug ID BADD_D00195
Description Azathioprine is a prodrug of 6-mercaptopurine, first synthesized in 1956 by Gertrude Elion, William Lange, and George Hitchings in an attempt to produce a derivative of 6-mercaptopurine with a better therapeutic index.[A189678,A189687,A189690] Azathioprine is used to treat inflammatory conditions like rheumatoid arthritis and as an immunosuppressant in the prevention of renal transplant rejection.[L11214] Azathiprine was granted FDA approval on 20 March 1968.[L11214]
Indications and Usage Anstey A, Lear JT: Azathioprine: clinical pharmacology and current indications in autoimmune disorders. BioDrugs. 1998 Jan;9(1):33-47.
Marketing Status Prescription; Discontinued
ATC Code L04AX01
DrugBank ID DB00993
KEGG ID D00238
MeSH ID D001379
PubChem ID 2265
TTD Drug ID D07QCE
NDC Product Code 72789-129; 51407-182; 46014-1110; 62991-2189; 12780-0300; 51927-2258; 48954-909; 51552-0779; 15308-0732; 42973-143; 68382-120; 38779-0312; 68382-119; 67877-492; 70771-1139; 65649-241; 68382-118; 67877-494; 54766-590; 68462-502; 0378-1005; 71610-124; 60219-2036; 70771-1140; 51927-0071; 65841-602; 68382-003; 71610-306; 42291-071; 60219-2037; 68084-229; 60219-1076; 70771-1141; 49452-0783; 65649-231; 67877-495; 67877-493; 66122-0009
Synonyms Azathioprine | Azothioprine | Imurel | Imuran | Immuran | Azathioprine Sodium | Sodium, Azathioprine | Azathioprine Sodium Salt | Azathioprine Sulfate
Chemical Information
Molecular Formula C9H7N7O2S
CAS Registry Number 446-86-6
SMILES CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Cyanosis02.01.02.002; 22.02.02.007; 24.03.01.0070.001436%
Cyst08.03.05.001; 16.02.02.0020.002872%Not Available
Cytomegalovirus infection11.05.01.0020.022258%
Death08.04.01.001--
Defaecation urgency07.02.04.0010.004308%Not Available
Dehydration14.05.05.001--
Delirium19.13.02.001--
Demyelination17.16.02.0010.005744%Not Available
Dental caries07.09.01.0010.002154%
Depressed level of consciousness17.02.04.002--
Depressed mood19.15.02.001--Not Available
Depression19.15.01.001--
Dermal cyst16.26.02.001; 23.10.02.0010.001436%Not Available
Dermatitis23.03.04.0020.002872%Not Available
Dermatomyositis10.04.02.001; 15.05.01.002; 23.03.02.0010.001436%Not Available
Diabetes mellitus05.06.01.001; 14.06.01.001--Not Available
Diarrhoea07.02.01.0010.059594%
Diarrhoea haemorrhagic07.02.01.002; 24.07.02.0040.006462%Not Available
Diffuse large B-cell lymphoma01.15.02.001; 16.28.02.0010.001686%Not Available
Discomfort08.01.08.003--Not Available
Disseminated intravascular coagulation01.01.02.002; 24.01.01.0100.000749%
Disseminated tuberculosis11.04.01.0010.012924%Not Available
Disturbance in attention17.03.03.001; 19.21.02.002--
Diverticulitis07.10.02.001; 11.01.07.0030.002154%Not Available
Dizziness02.01.02.004; 17.02.05.003; 24.06.02.007--
Drug dependence19.07.02.009--Not Available
Drug eruption08.01.06.015; 10.01.01.005; 23.03.05.0010.002154%Not Available
Drug hypersensitivity10.01.01.001--Not Available
Drug withdrawal syndrome08.06.02.004; 19.07.02.011--Not Available
Dry skin23.03.03.001--
The 5th Page    First    Pre   5 6 7 8 9    Next   Last    Total 27 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene